flecha

Product

flecha
Corlentor®
Corlentor® (Ivabradine) is a drug discovered and developed by Laboratoires Servier and is indicated in the symptomatic treatment of chronic stable angina in patients with normal sinus rhythm who have a contraindication or intolerance to beta blockers
Corlentor® (Ivabradine) is a drug discovered and developed by Laboratoires Servier and is indicated in the symptomatic treatment of chronic stable angina in patients with normal sinus rhythm who have a contraindication or intolerance to beta blockers.

Corlentor® reduces specifically the heart rate without impacting other cardiac parameters, and hence has beneficial clinical effects for cardiovascular diseases. It has been developed by Les Laboratoires Servier and has been marketed by ROVI since 2007.
 
Link More information
 
Permalink  
Delicious  Technorati  Facebook  Twitter  Meneame 
Search
linea
Google Custom Search
BioRegión Collaborative Area
BioRegión Collaborative Area
RSS
linea
RSS RSS Andalucía BioRegión
User Acces
linea
Email:
Password:

Register

Forgot your password?

Companies/centers Acces
line
Email:
Password:

Register your company

Forgot your password?

Tag cloud
line
View more tags
BioRegión Collaborative Area